Published in J Infect Dis on January 05, 2011
Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog (2013) 1.04
Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog (2013) 0.97
Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis. Viruses (2011) 0.97
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection. Semin Cancer Biol (2013) 0.94
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses (2011) 0.92
Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex. PLoS Pathog (2014) 0.87
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis. Retrovirology (2016) 0.87
Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives. Leuk Res Treatment (2012) 0.86
Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases. Viruses (2015) 0.86
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL. Retrovirology (2015) 0.84
The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases. Front Microbiol (2012) 0.83
Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma? Leuk Res Treatment (2011) 0.82
Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression. Retrovirology (2014) 0.82
Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl Trop Dis (2013) 0.82
Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status. Retrovirology (2016) 0.80
The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection. Retrovirology (2015) 0.79
Integration site and clonal expansion in human chronic retroviral infection and gene therapy. Viruses (2014) 0.78
Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence. Viruses (2015) 0.77
HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP. Virol J (2014) 0.77
Human T-cell leukaemia virus type 1: parasitism and pathogenesis. Philos Trans R Soc Lond B Biol Sci (2017) 0.76
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). PLoS Negl Trop Dis (2017) 0.75
HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection. Retrovirology (2015) 0.75
Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep (2016) 0.75
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A (1983) 14.09
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A (2006) 3.11
The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol (2002) 3.01
Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet (1990) 2.96
Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol (2007) 2.40
The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem (2003) 2.02
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood (2006) 1.98
Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology (1992) 1.94
HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology (2006) 1.87
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
Interleukin-2 in the development and control of inflammatory disease. Immunol Rev (2008) 1.83
HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene (2005) 1.66
An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses (1993) 1.66
Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol (2006) 1.63
Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol (1992) 1.59
In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology (2009) 1.58
A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol (2006) 1.58
HTLV-1 and polymyositis in Jamaica. Lancet (1989) 1.51
CTL quality and the control of human retroviral infections. Eur J Immunol (2009) 1.50
Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology (2008) 1.37
Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer (2000) 1.37
HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog (2010) 1.28
High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood (2002) 1.20
Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology (2009) 1.16
HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests. BMJ (2000) 1.15
Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J Virol (2009) 1.14
High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology (1996) 1.14
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis (2004) 1.04
HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol (2009) 1.00
High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (2000) 0.96
Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination. J Biol Chem (2008) 0.94
Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study. Cancer Causes Control (2003) 0.89
HTLV-I infection in patients with autoimmune thyroiditis (Hashimoto's thyroiditis). J Med Virol (1992) 0.88
Construction and characterization of a human T-cell lymphotropic virus type 3 infectious molecular clone. J Virol (2008) 0.88
Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology (2006) 0.83
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS (2002) 5.67
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science (2003) 5.19
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS (2014) 2.67
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol (2008) 2.67
The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood (2011) 2.11
Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol (2007) 1.76
Reduction of B cell turnover in chronic lymphocytic leukaemia. Br J Haematol (2008) 1.74
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses (2006) 1.67
Measurement and modeling of human T cell kinetics. Eur J Immunol (2003) 1.61
CellNOptR: a flexible toolkit to train protein signaling networks to data using multiple logic formalisms. BMC Syst Biol (2012) 1.60
B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood (2005) 1.52
Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J Biol Chem (2005) 1.45
HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog (2008) 1.45
Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol (2002) 1.44
Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood (2005) 1.44
High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood (2007) 1.43
Persistence of HTLV-I in blood components after leukocyte depletion. Blood (2002) 1.39
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A (2007) 1.36
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology (2007) 1.35
Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics (2012) 1.35
Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study. J Infect Dis (2007) 1.30
When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? AIDS (2012) 1.29
Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis. PLoS Negl Trop Dis (2009) 1.29
HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog (2010) 1.28
A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol (2005) 1.25
High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood (2002) 1.20
Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol (2004) 1.20
T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis (2013) 1.18
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood (2011) 1.18
High prevalence of macrolide resistant Treponema pallidum strains in a London centre. Sex Transm Infect (2011) 1.18
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. Retrovirology (2006) 1.17
Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS One (2008) 1.16
Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci (2007) 1.13
The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev (2009) 1.13
Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res Hum Retroviruses (2012) 1.13
HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood (2009) 1.12
HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood (2012) 1.11
Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis (2002) 1.08
The neurology of HTLV-1 infection. Pract Neurol (2009) 1.07
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression? AIDS (2008) 1.07
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood (2010) 1.05
FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int J Cancer (2009) 1.05
Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog (2013) 1.04
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis (2004) 1.04
Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog (2012) 1.03
Rapid turnover of T cells in acute infectious mononucleosis. Eur J Immunol (2003) 1.03
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog (2011) 1.02
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol (2010) 1.02
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci U S A (2002) 1.01
British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med (2014) 1.01
Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans. Blood (2013) 1.01
The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci (Landmark Ed) (2009) 1.00
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol (2006) 0.99
T-cell epitope prediction: rescaling can mask biological variation between MHC molecules. PLoS Comput Biol (2009) 0.99
The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol (2009) 0.99
Quantification of the virus-host interaction in human T lymphotropic virus I infection. Retrovirology (2005) 0.99
Pregnant women with HIV infection can expect healthy survival: three-year follow-up. J Acquir Immune Defic Syndr (2006) 0.99
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood (2007) 0.98
Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen. Blood (2011) 0.97
HTLV-1: persistence and pathogenesis. Virology (2013) 0.97
Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood (2011) 0.97
HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice. PLoS Pathog (2011) 0.96
Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labeled glucose. Nat Protoc (2009) 0.95